25G-NBOMe (NBOMe-2C-G) is a derivative of the
phenethylamine
Phenethylamine (PEA) is an organic compound, natural monoamine alkaloid, and trace amine, which acts as a central nervous system stimulant in humans. In the brain, phenethylamine regulates monoamine neurotransmission by binding to trace amin ...
hallucinogen 2C-G
2C-G is a psychedelic phenethylamine of the 2C family. First synthesized by Alexander Shulgin, it is sometimes used as an entheogen. It has structural and pharmacodynamic properties similar to 2C-D and Ganesha. Like many of the phenethylami ...
, which acts as a highly
potent partial agonist for the
human 5-HT2A receptor.
Legality
Sweden
The Riksdag added 25G-NBOMe to
Narcotic Drugs Punishments Act under ''swedish schedule I'' (''"substances, plant materials and fungi which normally do not have medical use"'') as of January 16, 2015, published by
Medical Products Agency (MPA) in regulation ''LVFS 2014:11'' listed as 25G-NBOMe, and 2-(2,5-dimetoxi-3,4-dimetylfenyl)-N-(2-metoxibensyl)etanamin.
United Kingdom
See also
*
2CBCB-NBOMe (NBOMe-TCB-2)
*
2CBFly-NBOMe (NBOMe-2CB-Fly)
*
2C-C-NBOMe
25C-NBOMe (NBOMe-2C-C, 2C-C-NBOMe, Cimbi-82) is a psychedelic drug and derivative of the psychedelic phenethylamine 2C-C. 25C-NBOMe appeared on online vendor sites in 2010 but was not reported in the literature until 2011.
It acts as a potent ag ...
(NBOMe-2CC)
*
25B-NBOMe
25B-NBOMe (NBOMe-2C-B, Cimbi-36, Nova, BOM 2-CB) is a derivative of the phenethylamine psychedelic 2C-B, discovered in 2004 by Ralf Heim at the Free University of Berlin. It acts as a potent full agonist for the 5HT2A receptor. Anecdotal rep ...
(NBOMe-2CB)
*
25I-NBOMe
25I-NBOMe (2C-I-NBOMe, Cimbi-5, Smiles and also shortened to "25I") is a synthetic hallucinogen that is used in biochemistry research for mapping the brain's usage of the type 2A serotonin receptor; it is also sometimes used for recreational pu ...
(NBOMe-2CI)
*
25I-NBMD
25I-NBMD (NBMD-2C-I, Cimbi-29) is a derivative of the phenethylamine hallucinogen 2C-I, discovered in 2006 by a team at Purdue University led by David Nichols. It acts as a potent partial agonist for the 5HT2A receptor
Receptor may refer to:
...
(NBMD-2CI)
*
25B-NBOH
25B-NBOH (2C-B-NBOH, NBOH-2C-B) is a derivative of the phenethylamine derived hallucinogen 2C-B which has been sold as a designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mi ...
*
25I-NBOH
25I-NBOH (NBOH-2CI, Cimbi-27, 2-C-I-NBOH) is a derivative of the phenethylamine-derived hallucinogen 2C-I that was discovered in 2006 by a team at Purdue University.
Pharmacology
25I-NBOH acts as a potent agonist of the 5HT2A receptor, with a ...
(NBOH-2CI)
References
{{Phenethylamines
25-NB (psychedelics)
Designer drugs